Stammzelltransplantation

MC-MSC.1 IDUNN	Phase III	Behandlung der steroidrefraktären akuten Graft-versus-Host-Krankheit mit mesenchymalen Stromazellen im Vergleich zur besten verfügbaren Therapie (IDUNN) NCT04629833
PKRPC001 / POA 20201	Phase IIIb	A prospective randomized, double-blind, placebo-controlled, multi-center phase III study to evaluate the efficacy and safety of mocravimod as an adjunctive and maintenance treatment in adult acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic cell transplantation (HCT) NCT05429632
FLAMSACLAX	Phase III	Phase-I/II trial to assess the safety and efficacy of Venetoclax in addition to sequential conditioning with Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for allogeneic blood stem cell transplantation in patients with MDS, CMML or sAM 2022-002435-66
EQUATOR EQ-100-02	Phase III	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Itolizumab in Combination with Corticosteroids for the Initial Treatment of Acute Graft Versus Host Disease 2021-004529-57
INCA 34176-254	Phase II	A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease Eudract Nr. 2022-502168-19-00
TASK	AWB	Therapieadhärenz bei Patienten mit Stammzelltransplantation bei einer hämatologischen Krebs-erkrankung (TASK) Fragebogenprojekt in Kooperation dem Universitätsklinikum Leipzig